RecallDepth
Class II Ongoing

Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-474-60.

This recall is currently active, issued April 5, 2023. It was issued by Ascend Laboratories, Llc.

Company
Ascend Laboratories, Llc
Recall Initiated
March 14, 2023
Posted
April 5, 2023
Recall Number
D-0533-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
13,560 bottles
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot #s: 22142462, 22142463, 22142464, Exp 5/2024; 22143000, 22143001, 22143002, Exp 6/2024.

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls